[Imported mycoses in Japan: their present status and problems]

Katsuhiko Kamei1

  • 1Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8673, Japan.

Insights

Imported fungal infections like coccidioidomycosis are rising in Japan, yet receive little medical attention. This review details coccidioidomycosis diagnosis and treatment, urging physician awareness of these serious imported mycoses.

Area of Science:

  • Medical Mycology
  • Infectious Diseases Epidemiology

Background:

  • Imported mycoses, specifically coccidioidomycosis and histoplasmosis, show a notable increase in Japan over the last 15 years.
  • Over 40 cases of each disease have been reported, indicating a growing public health concern.
  • Despite high infectivity and virulence, these imported fungal infections are under-recognized by medical professionals.

Purpose of the Study:

  • To provide a comprehensive overview of coccidioidomycosis, focusing on its diagnosis and treatment.
  • To discuss the significance and recent epidemiological trends of imported mycoses in Japan.
  • To emphasize the need for increased physician awareness and collaboration with clinical microbiologists regarding coccidioidomycosis.

Main Methods:

  • Literature review of imported mycoses, with a focus on coccidioidomycosis.
  • Analysis of reported patient cases and disease trends in Japan.
  • Synthesis of current knowledge on diagnosis and treatment strategies.

Main Results:

  • Coccidioidomycosis and histoplasmosis are increasingly reported in Japan.
  • Physicians require updated information and close collaboration with microbiologists for effective management.
  • The review consolidates key aspects of coccidioidomycosis for clinical practice.

Conclusions:

  • Imported mycoses, particularly coccidioidomycosis, represent a growing challenge in Japan.
  • Enhanced physician education and interdisciplinary communication are crucial for addressing these infections.
  • Proactive management and awareness are essential to combat the rising incidence of these virulent fungal diseases.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...